Smart sharps disposal for hemophilia treatment
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This study tests a new smart container for safely disposing of needles used in hemophilia treatment. It aims to make managing your medication easier and safer at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have moderate or severe hemophilia A or B, with or without an inhibitor.
- You are currently taking preventive treatment (prophylaxis) with factor product or emicizumab at least once every 14 days.
- You are able to use the new disposal container.
- You are not receiving any other investigational drugs during the study.
- You do not have a home nurse giving your infusions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called SR604, given as a shot under the skin, to help prevent bleeding in people with hemophilia A or B. If it works, it could reduce the number of bleeding episodes and make daily life easier.
This study tests a new medicine called KN057 for people with hemophilia A or B, with or without inhibitors, to see if it helps prevent bleeding. It is for people who still have frequent bleeding episodes despite current treatments.
This trial tests a new injection called GS1191-0445 for people with hemophilia A. It aims to see if it is safe and works well to prevent or treat bleeding episodes.
This study tests a new medicine called SKP-0141 to see if it can safely treat and prevent bleeding in people with severe hemophilia A. It might help reduce the number of bleeds and improve quality of life.
This study looks at how well a newer preventive treatment for hemophilia A works in everyday life. It collects real-world information from patients to help doctors tailor clotting therapy better.
This study tests whether KN057, a new preventive medicine, is safe for males with hemophilia A or B. It aims to help prevent bleeding episodes without causing unwanted blood clots.
Hear when a new Hemophilia A and B trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.